A group in Canada has created national competency frameworks for pharmacology education. These are shared lists of what students should know and be able to do. The work covered undergraduate and graduate pre-professional pharmacology programs across the country. This is a guideline, not a clinical trial, so there were no patients, treatments, or health outcomes measured.
The undergraduate framework sets out 12 key competencies and 32 supporting ones. The graduate framework sets out 17 key competencies and 58 supporting ones. The competencies cover core knowledge, skills, and attitudes, and the group found agreement across sectors on principles of drug action and therapeutic response.
No safety information was reported, because this work did not test a treatment. The report also does not describe its limitations, funding, or conflicts of interest, so it is hard to judge how the consensus was reached or who took part.
What this means for everyday readers is limited. These frameworks are meant to guide how pharmacology is taught and how students are prepared for professional work. They do not change anyone's care today, and they are not evidence about any drug or treatment.
Common questions
What are the new pharmacology competency frameworks?
They are shared national lists of what pharmacology students in Canada should know and be able to do. The undergraduate framework has 12 key and 32 supporting competencies. The graduate framework has 17 key and 58 supporting competencies. They are meant to guide curriculum design and professional preparation, not to test any treatment.
Who do these frameworks apply to?
They were developed for undergraduate and graduate pre-professional pharmacology programs in Canada. They describe expected knowledge, skills, and attitudes at each level. They are not aimed at patients or at changing anyone's medical care.
Were any treatments or patients studied?
No. This was a guideline and framework development project, not a clinical trial. No patients were treated, no drugs were tested, and no health outcomes or side effects were measured. The work focused on agreeing on what should be taught in pharmacology programs.
How certain are these results?
The report does not describe its limitations, funding, or conflicts of interest, so it is hard to judge how the agreement was reached or who took part. The frameworks reflect consensus among those involved. They are a starting point for curriculum planning rather than proof that any teaching approach works better.
